Skip to content
Skip to navigation
Skip to footer

Archive

View global media contacts

Home / Media Centre / Archive

Here you can find the archive of all Press Releases prior to 2022

Filter by date:

Showing 1107 press releases before 2022

Tagrisso granted Breakthrough Therapy Designation in the US for the adjuvant treatment of patients with Stage IB-IIIA EGFR-mutated lung cancer
30 July 2020
H1 2020 results
30 July 2020
Farxiga met all primary and secondary endpoints in groundbreaking Phase III DAPA-CKD trial for the treatment of patients with chronic kidney disease
28 July 2020
Calquence recommended for approval in the EU by CHMP for chronic lymphocytic leukaemia
27 July 2020
Imfinzi recommended for approval in the EU by CHMP for extensive-stage small cell lung cancer
27 July 2020
AstraZeneca and Daiichi Sankyo enter collaboration to develop and commercialise new antibody drug conjugate
27 July 2020
Breztri Aerosphere approved in the US for the maintenance treatment of COPD
24 July 2020
COVID-19 vaccine AZD1222 showed robust immune responses in all participants in Phase I/II trial
20 July 2020
Farxiga granted Fast Track Designation in the US for heart failure following acute myocardial infarction leveraging an innovative registry-based trial design
16 July 2020
Brilinta significantly reduced the rate of the composite of stroke and death in patients who had an acute ischaemic stroke or transient ischaemic attack in the Phase III THALES trial
16 July 2020

<
1
2
3
111
>

All of our latest press releases and articles are available to explore